Open AccessSafety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
Author(s) -
Joseph J. Eron,
Bonaventura Clotet,
J. Durant,
Christine Katlama,
Princy Kumar,
Adriano Lazzarin,
Isabelle PoizotMartin,
Gary Richmond,
Vincent Soriano,
Mounir AitKhaled,
Toshifumi Fujiwara,
Jane Huang,
Sherene Min,
Cindy Vavro,
Jane Yeo,
Sharon Walmsley,
Joseph Cox,
Jacques Reynes,
Philippe Morlat,
D. Vittecoq,
J.-M. Livrozet,
Pompeyo Viciana Fernández,
José M. Gatell,
Edwin DeJesus,
Jerome DeVente,
Jacob Lalezari,
Lewis McCurdy,
Louis A. Sloan,
Benjamin Young,
Anthony LaMarca,
Trevor Hawkins
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/3fft-xh11
Subject(s) - dolutegravir , raltegravir , human immunodeficiency virus (hiv) , medicine , virology , antiretroviral therapy , viral load